Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
Public ClinicalTrials.gov record NCT02785172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety and Efficacy of IDP-118 Lotion to Ultravate® Cream, in the Treatment of Plaque Psoriasis
Study identification
- NCT ID
- NCT02785172
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 154 participants
Conditions and interventions
Conditions
Interventions
- IDP-118 Vehicle Lotion Drug
- IDP-118 Vehicle Cream Drug
- IDP-118 Lotion Drug
- Ultravate Cream Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2016 (Actual)
- Primary completion
- Dec 2016 (Actual)
- Completion
- Jan 2017 (Actual)
- Last update posted
- Aug 20, 2020
2016 – 2017
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valeant Site 12 | Fullerton | California | 92831 | — |
| Valeant Site 04 | La Mesa | California | 91941 | — |
| Valeant Site 03 | San Diego | California | 92093 | — |
| Valeant Site 09 | San Diego | California | 92093 | — |
| Valeant Site 05 | Lauderdale Lakes | Florida | 33313 | — |
| Valeant Site 02 | Miami | Florida | 33111 | — |
| Valeant Site 07 | Fridley | Minnesota | 55421 | — |
| Valeant Site 08 | Chapel Hill | North Carolina | 27514 | — |
| Valeant Site 06 | Columbus | Ohio | 43085 | — |
| Valeant Site 13 | Mt. Pleasant | South Carolina | 29464 | — |
| Valeant Site 11 | Katy | Texas | 77449 | — |
| Valeant Site 10 | San Antonio | Texas | 78201 | — |
| Valeant Site 01 | Sugar Land | Texas | 77479 | — |
| Valeant Site 14 | Salt Lake City | Utah | 84103 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02785172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02785172 live on ClinicalTrials.gov.